David Happel Horizon Therapeutics Public LTD CO (HZNP) insider trading activity

HZNP Quotes by TradingView

David Happel is EVP, Commercial Dev & Strategy of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 5,089 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Oct 25, 2017, when has been sold 4,150 shares (Ordinary Shares) at a price of $13.53 per share, resulting in proceeds of $56,149. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.09K
0% 3M change
0% 12M change
Total Value Held $0

David Happel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 25 2017
SELL
Payment of exercise price or tax liability
$56,149 $13.53 p/Share
4,150 Reduced 44.92%
5,089 Ordinary Shares
Oct 25 2017
BUY
Exercise of conversion of derivative security
-
7,953 Added 46.26%
9,239 Ordinary Shares

Also insider at

SGMT
Sagimet Biosciences Inc.
President & CEO
DH

David Happel

EVP, Commercial Dev & Strategy
Dublin, L2

Track Institutional and Insider Activities on HZNP

Follow Horizon Therapeutics Public Ltd Co and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HZNP shares.

Notify only if

Insider Trading

Get notified when an Horizon Therapeutics Public LTD CO insider buys or sells HZNP shares.

Notify only if

News

Receive news related to Horizon Therapeutics Public Ltd Co

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HZNP